Articles with public access mandates - Andrew H. BeckLearn more
Not available anywhere: 3
Combination therapies including cilofexor and firsocostat for bridging fibrosis and cirrhosis attributable to NASH
R Loomba, M Noureddin, KV Kowdley, A Kohli, A Sheikh, G Neff, ...
Hepatology 73 (2), 625-643, 2021
Mandates: US National Institutes of Health
Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses’ Health Study
MA Healey, R Hu, AH Beck, LC Collins, SJ Schnitt, RM Tamimi, A Hazra
Breast cancer research and treatment 147, 639-651, 2014
Mandates: US National Institutes of Health
Earth mover's distance for differential analysis of heterogeneous genomics data
S Nabavi, AH Beck
2015 IEEE Global Conference on Signal and Information Processing (GlobalSIP …, 2015
Mandates: US National Institutes of Health
Available somewhere: 121
Comprehensive molecular portraits of human breast tumours
M MLL, P PIK3R1
Mandates: US National Institutes of Health
Comprehensive molecular portraits of invasive lobular breast cancer
G Ciriello, ML Gatza, AH Beck, MD Wilkerson, SK Rhie, A Pastore, ...
Cell 163 (2), 506-519, 2015
Mandates: US National Institutes of Health
Inconsistency in large pharmacogenomic studies
B Haibe-Kains, N El-Hachem, NJ Birkbak, AC Jin, AH Beck, HJWL Aerts, ...
Nature 504 (7480), 389-393, 2013
Mandates: US National Institutes of Health
A Diverse Array of Cancer-Associated MTOR Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity
BC Grabiner, V Nardi, K Birsoy, R Possemato, K Shen, S Sinha, A Jordan, ...
Cancer discovery 4 (5), 554-563, 2014
Mandates: US National Institutes of Health
Genome-wide association studies identify four ER negative–specific breast cancer risk loci
M Garcia-Closas, FJ Couch, S Lindstrom, K Michailidou, MK Schmidt, ...
Nature genetics 45 (4), 392-398, 2013
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
The reprogramming of tumor stroma by HSF1 is a potent enabler of malignancy
R Scherz-Shouval, S Santagata, ML Mendillo, LM Sholl, I Ben-Aharon, ...
Cell 158 (3), 564-578, 2014
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Human …
Three differentiation states risk-stratify bladder cancer into distinct subtypes
JP Volkmer, D Sahoo, RK Chin, PL Ho, C Tang, AV Kurtova, ...
Proceedings of the National Academy of Sciences 109 (6), 2078-2083, 2012
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, German …
Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function
A Papa, L Wan, M Bonora, L Salmena, MS Song, RM Hobbs, A Lunardi, ...
Cell 157 (3), 595-610, 2014
Mandates: US National Institutes of Health
Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma
B Edris, K Weiskopf, AK Volkmer, JP Volkmer, SB Willingham, ...
Proceedings of the National Academy of Sciences 109 (17), 6656-6661, 2012
Mandates: US National Institutes of Health
Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4
X Dai, W Gan, X Li, S Wang, W Zhang, L Huang, S Liu, Q Zhong, J Guo, ...
Nature medicine 23 (9), 1063-1071, 2017
Mandates: US National Institutes of Health, European Commission, Damon Runyon Cancer …
Transcriptional profiling of long non-coding RNAs and novel transcribed regions across a diverse panel of archived human cancers
AL Brunner, AH Beck, B Edris, RT Sweeney, SX Zhu, R Li, K Montgomery, ...
Genome biology 13, 1-13, 2012
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
PharmacoGx: an R package for analysis of large pharmacogenomic datasets
P Smirnov, Z Safikhani, N El-Hachem, D Wang, A She, C Olsen, ...
Bioinformatics 32 (8), 1244-1246, 2016
Mandates: Canadian Cancer Society, Canadian Institutes of Health Research, Ontario …
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers
JD French, M Ghoussaini, SL Edwards, KB Meyer, K Michailidou, ...
The American Journal of Human Genetics 92 (4), 489-503, 2013
Mandates: US National Institutes of Health, Cancer Research UK
The macrophage colony-stimulating factor 1 response signature in breast carcinoma
AH Beck, I Espinosa, B Edris, R Li, K Montgomery, S Zhu, S Varma, ...
Clinical cancer research 15 (3), 778-787, 2009
Mandates: US National Institutes of Health
Nanoscale imaging of clinical specimens using pathology-optimized expansion microscopy
Y Zhao, O Bucur, H Irshad, F Chen, A Weins, AL Stancu, EY Oh, ...
Nature biotechnology 35 (8), 757-764, 2017
Mandates: US National Science Foundation, US Department of Defense, US National …
Mammographic density and risk of breast cancer by age and tumor characteristics
KA Bertrand, RM Tamimi, CG Scott, MR Jensen, VS Pankratz, D Visscher, ...
Breast Cancer Research 15, 1-13, 2013
Mandates: US National Institutes of Health
Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression
P Lochhead, AT Chan, R Nishihara, CS Fuchs, AH Beck, E Giovannucci, ...
Modern Pathology 28 (1), 14-29, 2015
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program